Wu, Meng-Han
Valenca-Pereira, Felipe
Cendali, Francesca http://orcid.org/0000-0002-8874-2150
Giddings, Emily L.
Pham-Danis, Catherine
Yarnell, Michael C. http://orcid.org/0000-0002-4557-7255
Novak, Amanda J. http://orcid.org/0009-0009-8780-7395
Brunetti, Tonya M.
Thompson, Scott B.
Henao-Mejia, Jorge http://orcid.org/0000-0003-2044-1105
Flavell, Richard A. http://orcid.org/0000-0003-4461-0778
D’Alessandro, Angelo http://orcid.org/0000-0002-2258-6490
Kohler, M. Eric http://orcid.org/0000-0002-1181-0418
Rincon, Mercedes http://orcid.org/0000-0002-6663-2225
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA260909, CA223389, CA086913, P30CA046934)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI149187, AI148434)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels (634956)
Article History
Received: 17 October 2023
Accepted: 3 May 2024
First Online: 24 May 2024
Competing interests
: M.R. declares to be a member of the scientific advisory board and co-founder of Mitotherapeutix, and is co-inventor in patents held by the University of Vermont. M.R., M.E.K., M.W. and M.C.Y. declare the filing of a patent that discloses findings described in this manuscript. R.A.F. is an advisor to Glaxo Smith Kline, Celsius, EvolveImmune, Ventus Therapeutics, and is the recipient of a grant from Genetech/Roche. The remaining authors declare no competing interests.